Office Hours: Mon - Wed: 8 a.m. – 12 p.m., 1 p.m. – 4:30 p.m. | Thu - Fri: 8 a.m. – 12 p.m.

Treatment

Management of Reflux Disease

The management of gastroesophageal reflux disease (GERD) is guided by the severity of symptoms, objective findings, and individual patient factors. In many cases, a combination of lifestyle modifications and medical therapy is sufficient. In selected situations, surgical treatment may be appropriate.

The goal of treatment is to reduce pathological reflux, prevent mucosal injury, and improve quality of life, while taking into account the long-term implications of each therapeutic strategy.

Primary Goal

Resolution of symptoms and healing of inflammation

Secondary Goal

Prevention of recurrence and complications

Treatment Approaches

Depending on symptoms, diagnostic findings, and individual circumstances, different therapeutic approaches may be considered.
In many cases, lifestyle modifications are combined with medical therapy. In selected situations, surgical treatment may be appropriate.

Treatment Goal Examples Indications
Conservative Reduction of trigger factors and intra-abdominal pressure. Support of the body’s intrinsic regulation of the gastroesophageal junction. Early evening meals, smaller portion sizes, avoidance of individual trigger foods, elevation of the upper body during sleep, weight reduction, smoking cessation Mild symptoms, as a foundation of any treatment strategy, and as an adjunct to medication or following surgery
Medical Therapy Reduction of acid exposure or formation of a symptomatic barrier against reflux. Proton pump inhibitors (PPIs) effectively suppress gastric acid production. H2-receptor antagonists are less potent and used selectively. Alginates form a foamlike barrier on top of the gastric contents. PPIs, H2-receptor antagonists, alginates Clinically relevant symptoms, reflux esophagitis, as initial therapy or on-demand use
Surgical Long-term control of pathological reflux through a surgical intervention. The goal is to address the underlying cause rather than merely controlling acid exposure. Minimally invasive procedures (see section 'Surgical Procedures – Overview') Persistent symptoms despite adequate therapy, intolerance to medication, or when long-term medical therapy is not desired—following careful diagnostic evaluation

Lifestyle Modifications

Lifestyle measures are the initial cornerstone of treatment and may reduce symptoms, particularly in early or mild stages of the disease.

Nicotine and alcohol may impair the functional barrier at the gastroesophageal junction. Smoking cessation and reduction or avoidance of alcohol intake may therefore have a beneficial effect on reflux.

Medical Therapy

Treatment with proton pump inhibitors (PPIs) represents the established standard of care and leads to significant symptom relief in many patients. However, this approach targets acid production and does not address the underlying mechanical cause of the disease.

Long-term use of PPIs may be associated with adverse effects, including vitamin B12 and vitamin D deficiency, alterations in bone metabolism with an increased risk of fractures, and disturbances in magnesium absorption. Due to the reduced acid barrier of the stomach, gastrointestinal infections may also occur more frequently. In rare cases, inflammatory kidney changes or impaired renal function have been reported. In this context, many patients prefer a treatment strategy that does not require lifelong medication.

In such situations, and following appropriate diagnostic evaluation, surgical treatment may be considered. The goal is to restore the function of the gastroesophageal junction and thereby prevent reflux of gastric contents and acid into the esophagus.

Medications reduce acid—they do not correct the underlying cause.

Frequently Asked Questions

Do I need to continue taking reflux medication after surgery?

Following successful surgical restoration of the anatomical conditions, long-term use of acid-suppressing medication is generally no longer required.

Will I still be able to belch or vomit after surgery?

A key objective of the surgical technique is to preserve the natural function of the gastroesophageal junction. In the vast majority of cases, both the ability to belch and the ability to vomit are preserved.

Is the procedure durable, or can reflux recur?

In most cases, surgical treatment results in sustained symptom relief. Recurrence of reflux symptoms is possible in principle but overall very rare.

What are the risks associated with the procedure?

As with any surgical intervention, general risks such as bleeding, infection, or injury to adjacent structures exist. The procedure itself is well established and associated with an overall very low complication rate.

Who is a suitable candidate for surgical treatment of reflux disease?

Surgical treatment may be particularly appropriate for patients in whom conservative and medical therapies are insufficiently effective, not well tolerated, or when there is a desire to avoid long-term medication.

Patients with mechanically induced reflux of gastric contents or acid extending into the upper chest, throat, or mouth—particularly when lying down—tend to benefit most. In these cases, surgical restoration of the anatomical and physiological conditions may result in complete symptom resolution.

How is the procedure performed, and how long is the recovery in the hospital?

The procedure is performed using a minimally invasive approach. The hospital stay typically lasts two nights. Recovery continues gradually over several weeks, during which physical exertion should be temporarily limited.

What diagnostic evaluation is required prior to surgery?

A thorough preoperative evaluation is essential. This includes a detailed medical history and physical examination.

Upper endoscopy (gastroscopy) and assessment of esophageal motility using high-resolution esophageal manometry are mandatory.

Depending on the findings, additional testing may include measurement of acid exposure, either by 24-hour impedance-pH monitoring or by a 48-hour pH study using a BRAVO capsule.

In selected cases, contrast radiography of the esophagus and the gastroesophageal junction may be performed. Further diagnostic tests are guided by the individual clinical situation.

Do you have any questions? Contact us.

Mischa Feigel, MD
Board-certified surgeon (FMH)
Specialist in visceral surgery

Florastrasse 50
CH-8008 Zurich
Google Maps directions

Office Hours

Mon - Wed:
8 a.m. – 12 p.m.
1 p.m. – 4:30 p.m.

Thu - Fri:
8 a.m. – 12 p.m.